Advertisement
News
Advertisement

Boston Scientific wins international approvals for next-gen defibrillator wires

Mon, 09/24/2012 - 12:16pm
Mass Device

Medical device industry titan Boston Scientific lands approval to launch its next-generation Reliance 4-Front defibrillator leads in Europe and Asia.

Boston Scientific logo

Medtech titan Boston Scientific (NYSE:BSX) won regulatory approval to market its next-generation Reliance 4-Front defibrillator leads in Europe and Asia, the company announced today.

That may be good news for Boston Scientific's struggling cardiac rhythm management business, which experienced a 10% drop in sales during the company's 1st quarter.

The 4-Front device, which is not yet cleared by the FDA, features novel coatings designed to enhance the device's electrical properties and prevent tissue in-growth into defibrillation coils, according to a press release.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading